195 related articles for article (PubMed ID: 6196846)
21. Management of pancreatic neuroendocrine tumors.
Dabizzi E; Panossian A; Raimondo M
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):467-79. PubMed ID: 21139544
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.
Mutch MG; Frisella MM; DeBenedetti MK; Doherty GM; Norton JA; Wells SA; Lairmore TC
Surgery; 1997 Dec; 122(6):1012-9; discussion 1019-20. PubMed ID: 9426414
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
26. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
27. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic polypeptide update: its roles in detection of the trait for multiple endocrine adenopathy syndrome, type I and pancreatic polypeptide-secreting tumors.
Friesen SR; Tomita T; Kimmel JR
Surgery; 1983 Dec; 94(6):1028-37. PubMed ID: 6139885
[TBL] [Abstract][Full Text] [Related]
29. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
30. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
[TBL] [Abstract][Full Text] [Related]
31. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
32. Use of neuron-specific enolase as a serum marker for neuroendocrine neoplasms.
Prinz RA; Marangos PJ
Surgery; 1982 Nov; 92(5):887-9. PubMed ID: 7135210
[No Abstract] [Full Text] [Related]
33. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
Alfthan H; Haglund C; Roberts P; Stenman UH
Cancer Res; 1992 Sep; 52(17):4628-33. PubMed ID: 1324787
[TBL] [Abstract][Full Text] [Related]
34. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
35. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
[TBL] [Abstract][Full Text] [Related]
36. Endocrine tumors of the pancreas and their clinical syndromes.
Kaplan EL; Michelassi F
Surg Annu; 1986; 18():181-223. PubMed ID: 3001955
[No Abstract] [Full Text] [Related]
37. The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors.
Heitz PU; von Herbay G; Klöppel G; Komminoth P; Kasper M; Höfler H; Müller KM; Oberholzer M
Am J Clin Pathol; 1987 Oct; 88(4):467-72. PubMed ID: 2444098
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
Bordi C; Pilato FP; D'Adda T
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
[TBL] [Abstract][Full Text] [Related]
39. Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.
Blackman MR; Weintraub BD; Rosen SW; Kourides IA; Steinwascher K; Gail MH
J Natl Cancer Inst; 1980 Jul; 65(1):81-93. PubMed ID: 6248674
[No Abstract] [Full Text] [Related]
40. Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
Kuzmits R; Schernthaner G; Krisch K
Cancer; 1987 Sep; 60(5):1017-21. PubMed ID: 2440552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
